Montelucaste Bluepharma (Montelukast)

Montelukast, the active ingredient in Montelucaste Bluepharma, is a leukotriene receptor antagonist presented as a tablet for oral use. It treats asthma, allergic rhinitis and exercise‑induced bronchoconstriction in adults and children.

GNH USA supplies Montelucaste Bluepharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast is a leukotriene receptor antagonist used to manage conditions driven by leukotriene‑mediated inflammation.

- Asthma: improves control of chronic asthma and reduces the frequency of exacerbations. - Allergic rhinitis: relieves nasal congestion, sneezing and itching associated with seasonal or perennial allergic rhinitis. - Exercise‑induced bronchoconstriction: prevents airway narrowing that occurs during or after physical activity.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: occasional discomfort. - Cough: transient irritation. - Sore throat: mild irritation of the pharynx. - Nausea: occasional upset stomach. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Allergic reactions: rash, hives, or swelling. - Angioedema: swelling of face, lips or tongue. - Neuropsychiatric events: mood changes, agitation, or suicidal thoughts. - Stevens‑Johnson syndrome: severe skin reactions. - Hepatotoxicity: abnormal liver function tests. - Anaphylaxis: rare, life‑threatening hypersensitivity.

Before initiating therapy, consider the following precautions.

- Assess asthma control: ensure baseline control before adding Montelukast. - Monitor neuropsychiatric symptoms: watch for mood changes or suicidal ideation. - Use caution in hepatic impairment: adjust use if liver disease is present. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Review concomitant medications: consider potential drug interactions. - Store at below 25°C: keep in the original pack, protect from moisture.

Montelukast may interact with other medicines; awareness of interaction severity is important.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): may reduce efficacy. - Ritonavir: may lower plasma concentrations of Montelukast.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase risk of neuropsychiatric events. - Theophylline: monitor for additive bronchodilator effects. - Antihistamines: may enhance sedation in sensitive individuals.